Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity.

Source:http://linkedlifedata.com/resource/pubmed/id/17827390

Blood 2007 Dec 15 110 13 4588-98

Download in:

View as

General Info

PMID
17827390